| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02724046 | Meningitis, Meningococcal | Drug: Ciprofloxacin | Epicentre|Medecins Sans Frontieres, Netherlands | Phase 4 | 2017-01-01 | 2016-09-21 |
| NCT00992329 | Healthy | Drug: ciprofloxacin | University of Maryland|Food and Drug Administration (FDA) | Phase 1 | 2013-01-01 | 2013-11-21 |
| NCT02967341 | Childhood Cancer|Neutropenia | Other: Ciprofloxacin administration | Universitair Ziekenhuis Brussel | Phase 4 | 2016-03-01 | 2016-11-15 |
| NCT02773732 | Leukemia|Acute Myelogenous Leukemia|Acute Myeloid Leukemia | Drug: Ciprofloxacin|Drug: Etoposide | University of Florida | Phase 1|Phase 2 | 2016-09-01 | 2016-09-22 |
| NCT02961751 | Gonorrhoea | Drug: Ciprofloxacin | National Institute of Allergy and Infectious Diseases (NIAID) | | 2016-09-13 | 2017-03-02 |
| NCT01789203 | BK Virus Infection | Drug: Ciprofloxacin|Drug: placebo | The Methodist Hospital System | Phase 4 | 2013-01-01 | 2016-03-15 |
| NCT00609973 | Crohn's Disease | Drug: Ciprofloxacin|Drug: Placebo | University of North Carolina, Chapel Hill|Crohn's and Colitis Foundation|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | 2008-05-01 | 2013-03-21 |
| NCT01402947 | Healthy | Drug: Ciprofloxacin XR + MMX Placebo|Drug: MMX Mesalazine/mesalamine + Ciprofloxacin XR | Shire | Phase 1 | 2011-07-01 | 2012-06-01 |
| NCT01157819 | Otitis Externa|Otorhinolaryngologic Diseases|Ear Diseases|Otitis | Drug: 0.3% Ciprofloxacin Ear Drops|Drug: FoamOtic Cipro | Otic Pharma | Phase 2 | 2010-07-01 | 2011-03-14 |
| NCT00910351 | Pseudomonas Infection | Drug: Ciprofloxacin (Cipro, BAYQ3939) | Bayer | Phase 1 | 2009-07-01 | 2013-11-20 |
| NCT02661438 | Bronchiectasis|Pulmonary Disease, Chronic Obstructive | Drug: Placebo to Ciprofloxacin DPI (BAYQ3939) | Bayer|Novartis | | 2016-01-01 | 2016-04-06 |
| NCT00668044 | Burns|Bacterial Infections | Drug: Ciprofloxacin (BAYO9867)|Drug: Ciprofloxacin (BAYO9867) | Bayer | Phase 3 | 2002-11-01 | 2009-10-26 |
| NCT02326103 | Alcoholic Hepatitis|Alcoholic Cirrhosis | Drug: Ciprofloxacin|Drug: Placebo | Helsinki University | Early Phase 1 | 2015-04-01 | 2017-01-18 |
| NCT00431028 | Inflammation|Bacterial Infections | Device: slow delivery ciprofloxacin + triamcinolone | Federal University of S茫o Paulo | Phase 1|Phase 2 | 2005-09-01 | 2008-03-06 |
| NCT01753115 | Anthrax | Biological: BioThrax|Drug: Ciprofloxacin | Emergent BioSolutions|Department of Health and Human Services | Phase 2 | 2012-12-01 | 2014-11-18 |
| NCT02598362 | Urinary Tract Infection|Pyelonephritis | Drug: ciprofloxacin | University Hospital, Ghent|Universitair Ziekenhuis Brussel | Phase 4 | 2015-04-01 | 2015-11-04 |
| NCT00481689 | Urinary Tract Infections | Drug: Cipro XR (Ciprofloxacin, BAYQ3939) | Bayer | Phase 4 | 2004-05-01 | 2009-06-25 |
| NCT00785980 | Healthy | Drug: Quinine Sulfate Capsules 324 mg|Drug: Ciprofloxacin 500 mg|Drug: Quinine Sulfate Capsules 324 mg | Mutual Pharmaceutical Company, Inc. | Phase 1 | 2008-09-01 | 2012-07-31 |
| NCT00930982 | Bronchiectasis | Drug: Ciprofloxacin (Cipro, BAYQ3939)|Drug: Placebo | Bayer|Novartis | Phase 2 | 2009-06-01 | 2014-11-28 |
| NCT01319435 | Pharmacokinetics of Ciprofloxacin in Neonates | Procedure: Collection of biological samples | Liverpool Women's NHS Foundation Trust|University of Liverpool | Phase 1 | 2011-01-01 | 2015-10-09 |
| NCT01542801 | Adverse Reaction to Other Drugs and Medicines | Drug: Norfloxacin|Drug: ciprofloxacin | Korea University|Sungkyunkwan University|Kyungpook National University|Soon Chun Hyang University | Phase 4 | 2011-08-01 | 2016-12-27 |
| NCT00194532 | Urinary Tract Infection | Drug: Cefpodoxime|Drug: Ciprofloxacin | University of Washington | | 2005-06-01 | 2014-06-03 |
| NCT00741052 | Cholera | Drug: Ciprofloxacin|Drug: Azithromycin | International Centre for Diarrhoeal Disease Research, Bangladesh | Phase 3 | 2007-07-01 | 2011-07-11 |
| NCT01243437 | Plague | Drug: ciprofloxacin|Drug: doxyxcycline | Centers for Disease Control and Prevention|MRC/UVRI Uganda Research Unit on Aids|Ministry of Health, Uganda | Phase 2 | 2010-12-01 | 2012-09-10 |
